Alnespirone

This classification denotes a serotonin agonist and anxiolytic with the molecular formula C26H38N2O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 34E28BM822, chemically known as 8-azaspiro(4.5)decane-7,9-dione, 8-(4-((3,4-dihydro-5-methoxy-2h-1-benzopyran-3-yl)propylamino)butyl)-, monohydrochloride, (s)- but generally known as alnespirone, which bears US NIH Compound Identifier 121851. European Medicines Agency schedules Alnespirone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05353MIG. The term ALNESPIRONE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 8 No. 3 1994, List 34). ALNESPIRONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule alnespirone under HS 29349990 and SITC 51579. As of Q4 2014, ALNESPIRONE remains the US FDA Preferred Term for this commodity. Alnespirone bears US NLM identifiers UMLS ID C0753579 and NCI Concept Code C72689. SMILES: Cl.O=C1N(C(=O)CC2(CCCC2)C1)CCCCN(C1Cc2c(OC1)cccc2OC)CCC.